Article
NPAS2 dampens chemo-sensitivity of lung adenocarcinoma cells by enhancing DNA damage repair - Cell Death & Disease
Rating:
0.0
Views:
21
Likes:
1
Library:
1
Chemotherapeutic agents, including cisplatin, have remained a cornerstone of lung adenocarcinoma (LUAD) treatment and continue to play an essential role in clinical practice, despite remarkable progress in therapeutic strategies. Hence, a thorough comprehension of the molecular mechanisms underlying chemotherapeutic agent resistance is paramount.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value